Immunology × Rheumatology
The human immune system is a remarkable defense network—designed to identify threats, protect vital tissues, and maintain internal balance. Immunology explores how we respond to infection, inflammation, cancer, and misdirected self-reactivity. Rheumatology applies these principles clinically to disorders of joints, muscles, and connective tissues—many of which are autoimmune. Together, they’ve transformed care through targeted biologics and personalized strategies guided by immunologic markers.
Where the Fields Intersect
Most major rheumatic diseases—rheumatoid arthritis, lupus, vasculitis, scleroderma—are autoimmune. Their pathogenesis involves loss of tolerance, autoreactive B/T cells, innate immune amplification, and effector pathways that damage synovium, vessels, and connective tissue. Understanding these immune circuits enables precise therapies:
Immune Mechanisms → Disease
- Autoantibodies (e.g., anti-CCP, ANA) drive immune complex injury and complement activation.
- Pathogenic T cells (Th1/Th17) coordinate macrophage and neutrophil inflammation in synovium and vessels.
- Innate sensors (TLRs, inflammasome) amplify cytokines (TNF, IL-6, IL-1, IL-17).
- Fibroblast & endothelium remodeling underlies pannus formation, vasculitis, and sclerosis.
Therapeutic Targeting
- Biologics: anti-TNF, anti-IL-6R, anti-IL-17/23, anti-CD20 (B-cell depletion).
- Small molecules: JAK inhibitors modulate cytokine signaling; csDMARDs (MTX) re-balance immunity.
- Personalization: serologies (RF/anti-CCP/ANA), inflammatory markers, and organ involvement guide strategy.
- Comanagement: infection prevention, bone health, cardio-metabolic risk, and vaccination.